Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
Rocky L BakerBrenda BradleyTimothy A WilesRobin S LindsayGene BarbourThomas DelongRachel S FriedmanKathryn HaskinsPublished in: Journal of immunology (Baltimore, Md. : 1950) (2015)
T cells reactive to β cell Ags are critical players in the development of autoimmune type 1 diabetes. Using a panel of diabetogenic CD4 T cell clones derived from the NOD mouse, we recently identified the β cell secretory granule protein, chromogranin A (ChgA), as a new autoantigen in type 1 diabetes. CD4 T cells reactive to ChgA are pathogenic and rapidly transfer diabetes into young NOD recipients. We report in this article that NOD.ChgA(-/-) mice do not develop diabetes and show little evidence of autoimmunity in the pancreatic islets. Using tetramer analysis, we demonstrate that ChgA-reactive T cells are present in these mice but remain naive. In contrast, in NOD.ChgA(+/+) mice, a majority of the ChgA-reactive T cells are Ag experienced. Our results suggest that the presence of ChgA and subsequent activation of ChgA-reactive T cells are essential for the initiation and development of autoimmune diabetes in NOD mice.
Keyphrases
- type diabetes
- glycemic control
- cardiovascular disease
- high fat diet induced
- multiple sclerosis
- insulin resistance
- single cell
- innate immune
- cell therapy
- wild type
- magnetic resonance
- stem cells
- quantum dots
- skeletal muscle
- metabolic syndrome
- magnetic resonance imaging
- weight loss
- bone marrow
- antiretroviral therapy
- middle aged